60
Participants
Start Date
February 28, 2007
Primary Completion Date
June 30, 2008
Study Completion Date
December 31, 2008
Pegylated Interferon alpha 2a + Ribavirin
Pegaferon: Ampule, 180 microgram per week Ribaverin: Tablet, 10-15 mg/kg per day
Tehran Hepatitis Center, Tehran
Kermanshah University of Medical Sciences
OTHER
Tehran Hepatitis Center
OTHER